Who Paid My Doc
Phase IIB Study - F3 24 wk
Research payments
$746,098
Through program year 2021, $746,098 in research payments was reported against Phase IIB Study - F3 24 wk, across 81 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $353,880 | 1 |
| 2020 | Research | $239,275 | 22 |
| 2019 | Research | $152,943 | 58 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kevin Finnegan Hermitage, TN Named on 2 payments
- Anita Kohli Chandler, AZ Named on 2 payments
- Arun Khazanchi Lakewood Ranch, FL Named on 2 payments
- Stephen Harrison San Antonio, TX Named on 2 payments
- Steven Fern Creve Coeur, MO Named on 2 payments
- Aasim Sheikh Marietta, GA Named on 2 payments
- Jeffrey Rosen Coral Gables, FL Named on 1 payment
- Nadege Gunn Austin, TX Named on 1 payment
- Tarek Hassanein Coronado, CA Named on 1 payment
- Nikolaos Pyrsopoulos Newark, NJ Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.